Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
If you have diabetes, you should inform your doctor if you experience eye problems, such as changes in vision, during treatment with this medication
Efficacy Injections deliver medication directly into your system for predictable results
Additionally, the European Commission approved Gileads Vemlidy (Tenofovir Alafenamide, TAF) for the treatment of Chronic Hepatitis B Virus Infection, which is the first new treatment for chronic hepatitis B to be approved in Europe in nearly a decade.TAF is a targeted prodrug of tenofovir that has demonstrated antiviral efficacy similar to Viread, but at one-tenth the dose
e7 (2017)
compounding pharmacies when a clinician determines it may be appropriate for an individual patient
US$ 26.94
US$ 20.64
US$ 24.50
US$ 21.72
